Ticker brief
BEAT HEARTBEAM INC
Consumer, Non-cyclical · Healthcare-Products
last close
$0.3933
1 day
-1.2%
14 days
-18.1%
mkt cap
·
signals 14d
19
authors 14d
11
crowd 14d
+1.5σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-06 · now +0.15 (−1 bearish … +1 bullish)
Who spoke11
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @AlertsAndNews | C | -3.92 | 3 | +0.50 |
| @DavidScottAdams | C | -2.62 | 3 | +0.17 |
| @abc51648039 | C | -0.96 | 3 | +0.55 |
| @Tickeron | C | +1.53 | 3 | +0.38 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @DekmarTrades | C | -0.59 | 1 | +0.50 |
| @smith_will86715 | C | -3.74 | 1 | -0.75 |
| @BearaBullBella | C | -2.84 | 1 | +0.15 |
| @MrGannabc | C | -1.55 | 1 | +0.30 |
| @PrismMarketView | C | · | 1 | +0.60 |
| @SeegerErik | C | -1.23 | 1 | +0.75 |
Recent signals19of 19 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-06 | @Tickeron | +0.15 | Contrasts speculative BEAT with lower-risk MDT, whose story includes durable growth and raised guidance. | -32.7% | tweet ↗ |
| 2026-10-05 | @DavidScottAdams | +0.00 | Tomorrow's momentum watchlist without a stated entry or direction. | -39.9% | tweet ↗ |
| 2026-10-05 | @AlertsAndNews | +0.40 | Promotes prior swing alerts and targets after substantial gains had already occurred. | -39.9% | tweet ↗ |
| 2026-10-05 | @AlertsAndNews | +0.60 | Recaps completed alerts, entries and numerous targets hit across several momentum names. | -39.9% | tweet ↗ |
| 2026-10-05 | @Tickeron | +0.50 | FDA granted Breakthrough Device Designation to HeartBeam's at-home assessment system. | -39.9% | tweet ↗ |
| 2026-10-05 | @DavidScottAdams | +0.20 | Lists five stocks on a power-hour watchlist without explicit entry intent. | -39.9% | tweet ↗ |
| 2026-10-05 | @Tickeron | +0.50 | FDA granted Breakthrough Device Designation for HeartBeam's at-home technology. | -39.9% | tweet ↗ |
| 2026-10-05 | @abc51648039 | +0.65 | Celebrates BEAT reaching 0.9264 after a prior recommendation. | -39.9% | tweet ↗ |
| 2026-10-05 | @abc51648039 | +0.70 | Celebrates BEAT having risen to 0.83. | -39.9% | tweet ↗ |
| 2026-10-05 | @abc51648039 | +0.30 | Provides BEAT breakout, resistance and support levels without explicit entry intent. | -39.9% | tweet ↗ |
| 2026-10-05 | @SeegerErik | +0.75 | Reports a 110.75% gain in BEAT. | -39.9% | tweet ↗ |
| 2026-10-05 | @PrismMarketView | +0.60 | Lists the largest premarket gainers and decliners with percentage moves. | -39.9% | tweet ↗ |
| 2026-10-05 | @MrGannabc | +0.30 | Multi-stock watchlist provides trigger levels, targets, and support without entry intent. | -39.9% | tweet ↗ |
| 2026-10-05 | @BearaBullBella | +0.15 | Ticker pun with unavailable linked context | -39.9% | tweet ↗ |
| 2026-10-05 | @smith_will86715 | -0.75 | Warns BEAT holders of a stated $226M potential share overhang | -39.9% | tweet ↗ |
| 2026-10-05 | @DekmarTrades | +0.50 | Reports an FDA Breakthrough designation and adds a bullish wedge target. | -39.9% | tweet ↗ |
| 2026-10-05 | @DavidScottAdams | +0.30 | Identifies the listed stocks as morning movers. | -39.9% | tweet ↗ |
| 2026-10-05 | @OpenOutcrier | +0.50 | Reports FDA Breakthrough Device designation for HeartBeam's heart-attack assessment product. | -39.9% | tweet ↗ |
| 2026-10-05 | @AlertsAndNews | +0.50 | HeartBeam received FDA Breakthrough Device Designation for heart-attack assessment. | -39.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.